Is Fluoxetine Safe in Pregnancy
Status
cautionReason
Pregnancy use needs provider review. Official labeling says use only if benefit justifies fetal risk.
Drug Information
Safe Amount
Dosage must be determined by your provider based on individual risk/benefit.
Effects
- Pregnancy
- First-trimester exposure is not expected to greatly increase birth defect risk, but late-pregnancy use has been linked to newborn symptoms and possible preterm birth or low birth weight.
- Mother
- May help treat depression or anxiety, but untreated illness also carries pregnancy risks. Do not stop or start without prescriber guidance.
- Baby
- May cause poor neonatal adaptation, breathing trouble, feeding problems, jitteriness, or withdrawal-like symptoms after late pregnancy exposure.
Trimester Notes
- 1st Trimester
- Human data do not suggest a major increase in birth defects, but use still needs provider review.
- 2nd Trimester
- Continue only if benefits outweigh risks; monitor maternal mental health and fetal growth as advised by your provider.
- 3rd Trimester
- Late pregnancy exposure can cause newborn adaptation symptoms and may require longer hospital care or respiratory support.
Risk-Benefit Note
For antidepressants, the benefit of treating depression or anxiety in pregnancy may outweigh the risks for some patients. Untreated illness can also harm pregnancy. Review with your prescriber before changing treatment.
Conditions & Warnings
- Consult OB/GYN or prescriber
- Do not stop or continue without provider review
- Depression
- Anxiety disorders
- History of preterm birth
- History of low birth weight infant
Alternatives
- Talk therapy
- Other antidepressants only if your prescriber recommends them
- Non-medicine supports for depression or anxiety, such as counseling and sleep support
References
- FDA fluoxetine label (Prozac)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s108lbl.pdf - MotherToBaby Fluoxetine fact sheet
https://www.ncbi.nlm.nih.gov/books/NBK582711/
Black Box Warning: Antidepressants increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults.